BIOMAT Database Logo BIOMAT Database Logo

[Hemodynamic effect of cardiac glycosides in acute myocardial infarct]. 1979

A S Odintsova, and Iu A Karpov

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A S Odintsova, and Iu A Karpov
[Use of cardiac glycosides in acute myocardial infarct].
June 1972, Vrachebnoe delo,
A S Odintsova, and Iu A Karpov
[Hemodynamic effect of isosorbide-5-mononitrate in acute cardiac insufficiency secondary to myocardial infarct].
January 1989, Revista espanola de cardiologia,
A S Odintsova, and Iu A Karpov
[Treatment of myocardial infarct with cardiac glycosides].
December 1957, Munchener medizinische Wochenschrift (1950),
A S Odintsova, and Iu A Karpov
[Expediency of using cardiac glycosides in the treatment of acute myocardial infarct].
November 1970, Kardiologiia,
A S Odintsova, and Iu A Karpov
[Hemodynamic effect of mesocaine and ajmaline in acute myocardial infarct].
July 1979, Vnitrni lekarstvi,
A S Odintsova, and Iu A Karpov
[Hemodynamic effect of sublingual isosorbide dinitrate in acute myocardial infarct].
January 1980, Revista espanola de cardiologia,
A S Odintsova, and Iu A Karpov
[Hemodynamic observations in acute myocardial infarct].
February 1977, Kardiologiia,
A S Odintsova, and Iu A Karpov
[Hemodynamic variants of acute myocardial infarct].
January 1979, Kardiologiia,
A S Odintsova, and Iu A Karpov
[Hemodynamic evaluation of cardiac insufficiency in the acute stage of myocardial infarct].
September 1975, Zeitschrift fur Kardiologie,
A S Odintsova, and Iu A Karpov
[Cardiac glycosides and anticoagulants in therapy of myocardial infarct].
April 1956, Medizinische Klinik,
Copied contents to your clipboard!